Our Experts

At NDA we’re a team of experts – experts in the regulated disciplines, and experts in drug development.

Some of us have attained our experience from working inside regulatory authorities, carefully assessing the benefits and risks of new treatments. Some of us have worked for years in the biotech and pharmaceutical industry, patiently developing life changing products for patients suffering from debilitating and sometimes deadly diseases and conditions.

Whatever our background, we share a passion for the art and science of drug development and for making a difference to the clients and the patients we ultimately serve.

Get to know the people behind the passion – read more about our incredible team below.

01-10-2020

Dr Björn Carlsson

Director of the Advisory Board
Expert in non-clinical development and ATMPs
14-11-2022

Dr Chantal Van Gils

Advisory Board Director 
Expert in in real-world research, epidemiology and health economics.
09-03-2023

Dr Lisa Campbell

Senior Director
Expert in clinical drug development in the EU and UK.
01-10-2020

Dr Margarida Menezes Ferreira

Advisory Board Member
Expert in the strategic orientation for ATMP development
16-12-2022

Dr Marianne Scheel Fjording

Advisory Board Member 
Expert in regulated bioanalysis
01-10-2020

Dr Paula Salmikangas

Advisory Board Director
Expert in biological medicinal products
15-12-2023

Lisa Carlton

Principal Consultant
Expert in regulatory strategy, scientific affairs and medical writing.

Contact Us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.